13D Filing: Aisling Capital II LP and Adma Biologics Inc. (ADMA)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d...